TY - JOUR
T1 - Neuropsychiatric complications of injection-associated diseases
T2 - Hiv and hepatitis C
AU - Rado, Jeffrey
PY - 2017/1
Y1 - 2017/1
N2 - Intravenous use of illicit substances increases the risk for transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Both of these infections develop into chronic medical conditions with high morbidity and mortality. HIV and HCV may lead to significant neuropsychiatric and neurocognitive complications, including depression, fatigue, disturbed sleep, and cognitive impairment. Mental health providers need to be aware of these syndromes to initiate prompt evaluation and treatment. Furthermore, antiretroviral medications for HIV and direct-acting antivirals for HCV have their own neuropsychiatric side effects. Pegylated interferon for the treatment of hepatitis C, in particular, is strongly associated with depression. Finally, one must vigilantly monitor for possible drug-drug interactions when these agents are administered with psychotropic medications.
AB - Intravenous use of illicit substances increases the risk for transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Both of these infections develop into chronic medical conditions with high morbidity and mortality. HIV and HCV may lead to significant neuropsychiatric and neurocognitive complications, including depression, fatigue, disturbed sleep, and cognitive impairment. Mental health providers need to be aware of these syndromes to initiate prompt evaluation and treatment. Furthermore, antiretroviral medications for HIV and direct-acting antivirals for HCV have their own neuropsychiatric side effects. Pegylated interferon for the treatment of hepatitis C, in particular, is strongly associated with depression. Finally, one must vigilantly monitor for possible drug-drug interactions when these agents are administered with psychotropic medications.
UR - http://www.scopus.com/inward/record.url?scp=85010633326&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85010633326&partnerID=8YFLogxK
U2 - 10.3928/00485713-20161201-01
DO - 10.3928/00485713-20161201-01
M3 - Article
AN - SCOPUS:85010633326
SN - 0048-5713
VL - 47
SP - 38
EP - 44
JO - Psychiatric Annals
JF - Psychiatric Annals
IS - 1
ER -